VWF and COVID-19: Consistent with a state of hypercoagulability linked with a severe inflammatory response, coagulopathy is an important pathophysiological feature of COVID-19, characterized by the elevated fibrinogen levels, Von Willebrand Factor (VWF), and the fibrin degradation product (D-dimer, a fibrin degradation product that its increases are frequently reported in COVID-19 patients) (28).